Bispecific antibody therapy is transforming cancer treatment, especially in multiple myeloma, with ongoing studies exploring ...

Glenn Hussey went to The Ottawa Hospital for a regular checkup to monitor his smouldering multiple myeloma — a precursor to ...

Medically reviewed by Marla Anderson, MD Multiple myeloma is a rare type of blood cancer that forms in plasma cells, a white ...

This precancerous condition can progress to active multiple myeloma, a type of blood cancer. High-risk ... Multiple Myeloma: Cilta-Cel Found Highly Effective in Real-World Study Oct. 4 ...

In fact, it’s what happened to breast cancer survivor Evelyn Hunley. Fortunately for Evelyn, who thought she would only live for a few years, she was introduced to the MMRF and its many resources ...

A woman who feared she would not live to see her son turn 13 after being diagnosed with cancer has defied the prognosis and ...

A Glasgow grandad whose incurable cancer was dismissed as a pulled muscle is counting down the days until he finally gets to celebrate his ...

Delayed diagnosis causes a significant disadvantage for Hungarian patients adding cost and complexity to the already stretched healthcare system.

Arcellx's anito-cel shows promising efficacy and safety in multiple myeloma. Read why I maintain my hold rating for ACLX ...

A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings showcase a ...

Sanofi SA (NASDAQ:SNY) released results from the IRAKLIA phase 3 study evaluating the non-inferiority of Sarclisa (isatuximab ...

The expert knowledge presented at this year’s International Myeloma Society (IMS) annual meeting focused on minimal residual disease testing and status, defining and treating high-risk disease ...